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HPLC methodAbstract We studied the application of Taguchi orthogonal array (TOA) design during the devel-
opment of an isocratic stability indicating HPLC method for glimepiride as per TOA design;
twenty-seven experiments were conducted by varying six chromatographic factors. Percentage of
organic phase was the most signiﬁcant (p< 0.001) on retention time, while buffer pH had the most
signiﬁcant (p< 0.001) effect on tailing factor and theoretical plates. TOA design has shortcoming,
which identiﬁes the only linear effect, while ignoring the quadratic and interaction effects. Hence, a
response surface model for each response was created including the linear, quadratic and interaction
terms. The developed models for each response found to be well predictive bearing an acceptable
adjusted correlation coefﬁcient (0.9152 for retention time, 0.8985 for tailing factor and 0.8679 for
theoretical plates). The models were found to be signiﬁcant (p< 0.001) having a high F value
for each response (15.76 for retention time, 13.12 for tailing factor and 9.99 for theoretical plates).
The optimal chromatographic condition uses acetonitrile – potassium dihydrogen phosphate (pH
4.0; 30 mM) (50:50, v/v) as the mobile phase. The temperature, ﬂow rate and injection volume were
An integrated Taguchi and response surface methodological approach 93selected as 35 ± 2 C, 1.0 mL min1 and 20 lL respectively. The method was validated as per ICH
guidelines and was found to be speciﬁc for analyzing glimepiride from a novel supersaturatable self-
nanoemulsifying formulation.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Glimepiride (GLP): {N-[4-[2-(3-ethyl-4-methyl-2-oxo-3-pyrro-
line-1-carboxamido)-ethyl]-benzenesulfonyl]-N0-4-methylcyclo-
hexylurea} is a sulfonylurea antidiabetic drug. It is given orally
for the treatment of type II diabetes mellitus and lower blood
glucose by stimulating the insulin release from pancreatic b cell
(Sweetman, 2009). GLP is a poorly water-soluble drug having
a logP (octanol/water) value of 3.81 with a pKa of 6.2
(Brittain, 2009).
Self-nanoemulsifying drug-delivery systems are technologi-
cal advances of lipid based drug delivery with a huge potential
to improve oral bioavailability of poorly soluble drug
(Bandyopadhyay et al., 2012). More recently, there has been
an increasing focus on the application of the supersaturatable
self-nanoemulsifying drug delivery system (S-SNEDDS) (Gao
and Morozowich, 2006; Wei et al., 2012). S-SNEDDS
preconcentrates are an isotropic mixture of oil, surfactant,
co-surfactant, polymeric precipitation inhibitor (PPI) and drug
that forms a ﬁne oil-in-water nanoemulsion, when introduced
into an aqueous medium under mild agitation. The PPI pre-
vents the drug from precipitating out of the solution, thus
maintaining a supersaturated state (Gao et al., 2009). With this
direction, S-SNEDDS for GLP was formulated to enhance its
solubility (unpublished data).
However, there was a need to develop a robust stability
indicating method to quantify GLP during drug excipients
compatibility testing as well as for routine assay and stability
studies of the said formulation. Numbers of HPLC methods
exist to quantify GLP alone or in combination from pharma-
ceutical dosage form (Bansal et al., 2008; Bonﬁlio et al., 2013;
El-Enany et al., 2012; El Deeb et al., 2006; Jain et al., 2008;
Karthik et al., 2008; Khan et al., 2005; Kovarı´kova´ et al.,
2004; Lakshmi and Rajesh, 2011; Maier et al., 2009; Pandit
et al., 2012; Shaodong et al., 2010; Yao et al., 2007) and bio-
logical matrices (Aburuz et al., 2005; Chakradhar et al.,
2008; El-Enany et al., 2012; Lakshmi and Rajesh, 2011;
Musmade et al., 2011; Pistos et al., 2005; Polagani et al.,
2013; Salem et al., 2004; Samala, 2011; Tripathi et al., 2013).
However, neither of the methods discuss regarding quantita-
tive estimation of GLP from emulsions as the ﬁnal product.
Operating parameters such as the percentage of organic phase,
mobile phase pH, ﬂow rate, injection volume, buffer molarity,
and temperature play a critical role in controlling selectivity in
reverse phase HPLC separations (Ahuja and Rasmussen,
2007). Hence, Proper optimization of the chromatographic
parameters is needed to achieve a chromatogram having a
desired system suitability parameter. The conventional way
of optimizing an HPLC method that uses the one-factor-at-
a-time (OFAT) approach has its own limitations as this
approach is time-consuming, requires a larger number of
experiments, and frequently fails to project the true optimal
condition (Bezerra et al., 2008). In most situations, thedeveloped method requires further improvement thus slowing
the drug development process (Awotwe-Otoo et al., 2012).
An experimental design approach by which multivariate
data can be handled and ﬁtted to an empirical function offers
a better choice over OFAT for identiﬁcation and control of
critical factors (Hibbert, 2012). TOA design, which offers
recognition of the factor’s main effect in relatively few experi-
ments, is being used widely in the manufacturing section for its
robust optimization of process parameters (Aggarwal et al.,
2008; Chang et al., 2007; Kwak, 2005). Taguchi orthogonal
array (TOA) design uses a special set of arrays, gives the mini-
mum number of experiments with maximum information
about the inﬂuence of factors involved in the study. The term
‘‘orthogonal’’ means balanced, separable or not mixed; hence,
the inﬂuence of an individual factor is not mixed up with the
inﬂuence of other factors and is separated as a main effect of
the said factor (Taguchi, 1987). The effect of a single factor
can be a linear, quadratic or higher order, but the model
assumes that there are no interactions among the individual
factors (Montgomery, 2013). Hence, to overcome these short-
comings of TOA design, as an additional measure, a response
surface methodology (RSM) was applied to create a mathe-
matical model for each response that can be used to predict
the optimal condition. A combined TOA design and RSM
approach, which offers an edge over TOA design alone, has
been widely used for process optimization (Kwak, 2005;
Sarıkaya and Gu¨llu¨, 2014).
The aim of our study was to apply a TOA design combined
with RSM for robust optimization of a stability indicating
HPLC method for GLP with enhanced system suitability
parameters that can be used for subsequent assay of GLP from
an S-SNEDDS formulation.
2. Materials and methods
2.1. Chemicals and reagents
GLP USP was kindly supplied by Alembic Ltd. (Vadodara,
India). EP/NF grade medium chain tri-glycerides (Captex
300) and medium chain mono-glycerides (Capmul MCM)
were supplied by Abitec Corp., Janesville, USA. EP grade
poly-glycol mono and di-esters of 12-hydroxy stearic acid
(Solutol HS 15) was provided by BASF SE, Ludwigshafen,
Germany. Hydroxypropyl methylcellulose grade E5 (HPMC
E5) was supplied by Colorcon Asia Pvt. Ltd., Mumbai,
India. Size ‘‘1’’ hard gelatin capsule shell was supplied by
Capsugel Health Care Ltd., Mumbai, India. Methanol
(HPLC), acetonitrile (HPLC), potassium dihydrogen phos-
phate (chromatography), sodium metabisulphite (AR),
calcium carbonate (GR) and talc (GR) were purchased from
Merck Specialties Pvt. Ltd., Mumbai, India. Ortho phosphoric
acid (AR), hydrochloric acid (37% v/v) (AR), sodium hydrox-
ide (AR) and hydrogen peroxide (30% v/v) (AR) were
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Water (HPLC grade) was obtained in-house from a Direct Q-3
UV water puriﬁcation system (Millipore India Pvt. Ltd.,
Bengaluru, India).
2.2. Equipment
The HPLC system consisted of a quaternary pump (series 200,
Perkin Elmer), auto sampler (series 200, Perkin Elmer), and
temperature-controlled column oven (series 200, Perkin
Elmer). The UV–VIS detector (series 200, Perkin Elmer) was
operated at a wavelength of 229 nm. Data collection and
analyses were performed using Totalchrom workstation, ver-
sion 6.3.1.0504 (Perkin Elmer Inc., USA). Columns used were
Luna C8, 100 · 4.6 mm, 3.0 lm (Phenomenex, USA), and
Hypersil BDS C8, 100 · 4.6 mm, 3 lm (Thermo Scientiﬁc,
UK).
2.3. Preparation of stock and standard solution
The stock solution of GLP (1000 lg mL1) was prepared in
methanol. The standard solution (100 lg mL1) was prepared
by diluting the stock solution in methanol. The calibration
samples were prepared by dilution of the standard solution
with the mobile phase. The buffer was prepared by dissolving
4082 mg (30 mM) of potassium dihydrogen phosphate in 1 L
of HPLC grade water, and the pH was adjusted to 4.0 with
o-phosphoric acid.
2.4. Design of experiment
A six-factor three-level TOA design consisted of L27 array (3
6)
for the optimization of the HPLC method. The factors selected
were percentages (v/v) of acetonitrile (A), buffer pH (B), ﬂow
rate (mL min1) (C), injection volume (lL) (D), column oven
temperature (C) (E) and buffer molarity (mM) (F). The
experimental plans were designed using Minitab version 16
(Minitab, Inc. Coventry, UK). The scheme of experimental
design is presented in Table 1. As per the TOA design,
twenty-seven experiments were performed to evaluate the
responses such as retention time (RT), tailing factor (TF),
and theoretical plates (TP). The goal of this optimization
was set to minimize the tailing factor (62.0) and maximize
theoretical plates (>2500) on a minimum run time with an
acceptable resolution (P1.8) between GLP and its nearest
degradation peak. However, the resolution between GLP
and degradants was not considered as a response due to the
discontinuities of the resolution with changes in selectivity
(Rafamantanana et al., 2012).
Signal-to-noise (S/N) ratio, which is an important quality
characteristics of TOA design, was computed as below in
Eq. (1).
S=N ¼ 10 1
n
ðy21 þ y22 þ . . . þ y2nÞ
 
ð1Þ
where y1, y2, . . ., yn are the responses for a trial condition
repeated n times and S/N ratio of each response was computed
for each trial. The main effects of factors along with their per-
centage contribution were computed. The difference between
highest and lowest values of S/N ratio or means was used tocalculate the delta values. The delta values along with percent-
age contributions were used to rank the individual factor
(Shaligram et al., 2008). Main effect analysis of variance (main
effect ANOVA) was applied to validate the developed model.
Statistical ‘‘p value’’ less than 0.05 (p< 0.05) was considered
as signiﬁcant.
Similarly, for RSM models, the experimental data were
analyzed by response surface regression using Statistica ver-
sion 10.0 (Stat soft, Inc., Tulsa, OK, USA). A second order
polynomial equation satisfying the linear, quadratic and inter-
action effects of six studied factors was generated as below in
Eq. (2).
Y ¼ b0 þ b1X1 þ b11X21 þ b2X2 þ b22X22 þ b3X3 þ b33X23
þ b4X4 þ b44X24 þ b5X5 þ b55X25 þ b6X6
þ b66X26b12X1X2 þ b13X1X3 þ b23X2X3 þ b14X1X4
þ b24X2X4 þ b34X3X4 þ b16X1X6 þ b26X2X6
þ b36X3X6 þ b46X4X6 þ b15X1X5 þ b25X2X5
þ b35X3X5 þ b45X4X5 þ b65X6X5 ð2Þ
where Y, the response to be modeled; b0, the arithmetic mean
response; b1, b2, b3, b4, b5 and b6 are the regression coefﬁcient
of factors X1, X2, X3, X4, X5 and X6 respectively.
A positive coefﬁcient indicates a synergistic effect, while a
negative one represents an antagonistic effect of the concerned
factor upon the response Y.
Contour graphs were drawn to visualize the region of opti-
mum chromatographic conditions. Residual plots were con-
structed and inspected to test the adequacies of the
developed models. Analysis of variance (ANOVA) was applied
to validate the developed models. Derringer’s desirability was
computed and was used along with S/N ratio and other sta-
tistical parameters to optimize the method satisfying optimiza-
tion goal.
2.5. Method validation
To conﬁrm its suitability for its intended purpose, the method
was validated in accordance with the ICH guidelines (ICH
Q2R1, 2005) for system suitability, linearity, speciﬁcity, preci-
sion, accuracy, limit of detection, limit of quantiﬁcation and
robustness.
2.5.1. Linearity
Linearity was evaluated by injecting a series of ranging from
0.05 to 200 lg mL1, including 0.05, 0.1, 0.2, 0.5, 1, 5, 10,
20, 30, 50, 70, 100, 150, and 200 lg mL1. 20 lL injections
were made six times for above concentrations. A linear regres-
sion analysis was performed between the employed concentra-
tions (lg mL1) and peak areas (lV s) obtained.
2.5.2. Precision
The precisions of the proposed HPLC method were deter-
mined by injecting three different concentrations at low
(LOQ), mid and high end of the calibration curve. The selected
concentrations were 0.05, 30, and 100 lg mL1. For intra-day
variation, sets of six replicates of the above three concentra-
tions were analyzed on the same day; for inter-day variation,
six replicates were analyzed on six different days.
Table 1 Scheme of experimental design for HPLC method development of GLP.
Run A B C D E F Retention time (min) Tailing factor Theoretical plates
Observed Predicted Observed Predicted Observed Predicted
1 30 3.00 0.50 10 25.0 10 25.17 24.12 0.99 0.98 4156 4143
2 30 3.00 0.50 10 32.5 25 13.51 13.97 1.06 1.04 6522 6378
3 30 3.00 0.50 10 40.0 40 10.74 11.32 1.13 1.14 8341 8496
4 30 4.75 0.85 20 25.0 10 18.88 21.02 1.11 1.11 6895 7116
5 30 4.75 0.85 20 32.5 25 11.72 10.69 1.12 1.13 8112 8005
6 30 4.75 0.85 20 40.0 40 8.99 7.87 1.22 1.19 8892 8776
7 30 6.50 1.20 30 25.0 10 25.50 24.40 1.41 1.40 9712 9502
8 30 6.50 1.20 30 32.5 25 13.32 13.88 1.41 1.40 8794 9044
9 30 6.50 1.20 30 40.0 40 10.35 10.88 1.42 1.42 8510 8469
10 45 3.00 0.85 30 25.0 25 6.04 5.34 1.27 1.21 6627 6309
11 45 3.00 0.85 30 32.5 40 4.77 5.19 1.30 1.33 6502 6364
12 45 3.00 0.85 30 40.0 10 9.06 9.33 1.06 1.07 5091 5545
13 45 4.75 1.20 10 25.0 25 5.49 5.16 1.21 1.25 7315 7122
14 45 4.75 1.20 10 32.5 40 4.65 3.59 1.31 1.27 7310 7223
15 45 4.75 1.20 10 40.0 10 7.75 9.13 1.13 1.12 7485 7764
16 45 6.50 0.50 20 25.0 25 15.72 16.74 1.43 1.44 9015 9524
17 45 6.50 0.50 20 32.5 40 12.52 13.15 1.48 1.47 8575 8799
18 45 6.50 0.50 20 40.0 10 26.73 25.07 1.41 1.40 13021 12286
19 60 3.00 1.20 20 25.0 40 2.67 4.32 1.50 1.50 5674 6408
20 60 3.00 1.20 20 32.5 10 4.75 4.11 1.16 1.16 6273 6048
21 60 3.00 1.20 20 40.0 25 3.13 2.10 1.32 1.30 6819 6309
22 60 4.75 0.50 30 25.0 40 6.24 4.85 1.50 1.50 6161 5881
23 60 4.75 0.50 30 32.5 10 9.98 11.03 1.22 1.25 8382 8468
24 60 4.75 0.50 30 40.0 25 6.67 6.99 1.44 1.39 7712 7904
25 60 6.50 0.85 10 25.0 40 6.96 6.68 1.47 1.45 6079 5624
26 60 6.50 0.85 10 32.5 10 14.68 14.25 1.34 1.30 9432 9569
27 60 6.50 0.85 10 40.0 25 8.10 8.79 1.30 1.35 8735 9052
A, percentage (v/v) of acetonitrile; B, buffer pH; C, ﬂow rate (mL min1); D, injection volume (lL); E, temperature of column oven (C) and F,
buffer molarity (mM).
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Accuracy of the developed method was tested by fortifying a
mixture of degraded samples with the three different concentra-
tions of GLP (16, 20, and 24 lg mL1 equivalent to 1.6, 2.0,
and 2.4 mg) at 80%, 100%, and 120% levels and determining
the recovery of added drug. The peak area of the standard
was calculated by taking the difference between the peak area
of fortiﬁed and unfortiﬁed samples. Three replicates of each
concentration level were prepared and injected. The percentage
recoveries of GLP at each level (n= 3), along with mean per-
centage recovery from total injections (n= 9) were determined.
2.5.4. LOD and LOQ
Limit of detection (LOD) was deﬁned as the lowest concentra-
tion of GLP resulting in a signal-to-noise ratio of 3:1, and limit
of quantiﬁcation (LOQ) was expressed as a signal-to-noise
ratio of 10:1. Due to the difference in detector response, varied
concentrations ranging between 0.01 and 0.1 lg mL1 were
prepared and analyzed.
2.5.5. Speciﬁcity
Speciﬁcity is the ability to assess unequivocally the analyte in
the presence of components, which may be expected to be pre-
sent. Typically, these might include impurities, degradants,
matrix, etc. The speciﬁcity of the assay was determined by
the complete separation of GLP in the presence of its degrada-
tion products generated under stress conditions as well as from
the excipients of GLP S-SNEDDS.2.5.6. Robustness of the method
Robustness of any analytical procedure is ‘‘a measure of its
capacity to remain unaffected by small, but deliberate varia-
tions in method parameters and provides an indication of its
suitability during normal usage’’ (International conference on
harmonisation of technical requirements for registration of
pharmaceuticals for human use, 2005). A method is robust if
it is unaffected by small changes in operating conditions.
Robustness of the method was evaluated by deliberately alter-
ing few parameters. The parameters included variation of C-8
columns from different manufacturers, the percentage (v/v) of
acetonitrile in the mobile phase, buffer pH, ﬂow rate
(mL min1), column oven temperature (C) and buffer
molarity (mM). Two analytical columns, one Luna C8,
100 · 4.6 mm, 3.0 lm (Phenomenex, USA), and the other
Hypersil BDS C8, 100 · 4.6 mm, 3 lm (Thermo Scientiﬁc,
UK) were used during the experiment. Composition of acetoni-
trile in mobile phase was varied by 50 ± 1.0 percentages (v/v),
while buffer pH was varied by 4.0 ± 0.1 units. The ﬂow rate
was varied by 1.0 ± 0.05 mL min1, column oven temperature
was varied by 35 ± 2 C, and buffer molarity was varied by
30 ± 2 mM. Each factor selected (except columns from differ-
ent manufacturers), were changed at three levels. One factor at
a time was changed to estimate the effect. Replicate injections
(n= 6) of standard solution (20 lg mL1) were performed
under small changes of above six chromatographic parameters.
The mean ± SD (n= 6) of response was calculated for each
level variation due to a particular factor. In addition, the
96 R.N. Dash et al.mean ± SD along with% RSD was calculated for all three or
two levels (n= 18 or n= 12) for each factor.
2.5.7. System suitability
System-suitability test for retention time, theoretical plates and
tailing factor, was evaluated for six replicates injections of
GLP (20 lg mL1).
2.6. Forced degradation studies
The stability indicating the nature of the developed HPLC
method was studied by forced degradation of GLP under
following stressed conditions. The resultant solutions from
different conditions were diluted with mobile phase to obtain
GLP concentration equal to 20 lg mL1.
2.6.1. Hydrolytic conditions: acid, alkali, and water induced
degradation
Two mL of the standard stock solution was transferred to each
of three 10-mL volumetric ﬂasks, and the volume was made up
to the mark with 2 M hydrochloric acid, 1 M sodium hydrox-
ide, and water separately. Acid and base induced degradation
samples were kept at room temperature for 48 h while the
hydrolytic induced degradation sample was kept for 5 days
at 80 C in a thermostatic oven.
2.6.2. Oxidizing conditions: hydrogen peroxide induced
degradation
Two mL of the standard stock solution was transferred to a
10-mL volumetric ﬂask, and the volume was made up to the
mark with 3% (v/v) H2O2. This was kept at room temperature
for 6 h.
2.6.3. Thermal conditions: dry heat and moist heat induced
degradation
Two mL of the standard stock solution was transferred to each
of two 10-mL volumetric ﬂask, and the volume was made up to
the mark with methanol. These were kept at 80 C in a thermo-
static oven and water bath respectively. Dry heat and moist
heat samples were stressed for 24 h and 48 h respectively.
2.6.4. Photochemical degradation
Two mL of the standard stock solution was transferred into a
10-mL volumetric ﬂask and made the volume up to the mark
with methanol and was kept under direct sunlight for seven
days.
2.7. Sample collection, storage, and preparation
Before collecting samples, volume was made up to the mark
with respective solvent. One mL of the sample was collected
from each stressed condition. The samples from acid, base
and oxidation induced degradation were neutralized by adding
1 mL of appropriate strength of sodium hydroxide, hydrochlo-
ric acid, and sodium metabisulphite. All samples were stored at
2–8 C in the refrigerator before analysis. On the day of analy-
sis, samples were diluted with mobile phase up to 10 mL and
mixed.
A degradation mixture was prepared by mixing 1 mL of
diluted samples from all conditions. Prior to injection intoHPLC, all samples were ﬁltered with 0.22 lm membrane syr-
inge ﬁlter. At ﬁrst, the degradation mixture was injected to
optimize the run time, followed by injection of the individual
degradation samples six times.
2.8. Preparation of GLP S-SNEDDS and determination of drug
content
The S-SNEDDS of GLP was prepared by dissolving GLP
(0.25 g) into a 10 g mixture of Oil/Captex 300 (30% w/w),
Surfactant/Solutol HS 15 (45% w/w) and Co-surfactant/
Capmul MCM (25% w/w). The mixtures were mixed for
5 min with a Cyclo-mixer (Remi, model CM101, Mumbai,
India) to get a clear solution. 5% w/w equivalent to 0.5 g of
HPMC E5 (PPI) was added to the above solution and was
mixed vigorously to obtain a uniform suspension. The liquid
formulation was converted into free ﬂowing solid one by
adsorbing onto calcium carbonate (15 g), talc (2 g) followed
by sieving through sieve no. 40. Similarly, a blank
S-SNEDDS was prepared using above excipients in same pro-
portion but without using GLP.
For determining drug content, 20 capsules were weighed
and mixed. Powder equivalent to 3 mg of GLP was transferred
into a 100 mL volumetric ﬂask, and the volume was made up
to mark with the mobile phase and was subjected to sonication
for about 10 min to solubilize GLP. The resulting solution was
ﬁltered through a 0.22 lm nylon ﬁlter and injected six times
into the HPLC system. Similarly, a blank was prepared in
the same way by using blank S-SNEDDS. This process was
repeated for three consecutive days. The percentage recovery
for each solution (n= 6), and mean percentage recovery
(n= 18) were determined.
3. Results and discussion
3.1. Preliminary investigation
In this study, maximum numbers of factors such as percentage
(v/v) of organic phase, buffer pH, ﬂow rate, injection volume,
column oven temperature and buffer molarity that affects
retention and efﬁciency in HPLC were selected (Ahuja and
Rasmussen, 2007; Snyder et al., 2010). The ranges of individ-
ual factors within which a distinct variation of the capacity
factor (2–10) can be achieved, were selected based upon the
preliminary univariate investigation.
3.2. Analysis of the main effect plot
By visually inspecting the main effect plot of means (Fig. 1a),
it shows that retention time was decreased linearly with an
increase in percentage (v/v) of acetonitrile (A), ﬂow rate
(mL min1) (C) and buffer molarity (F). No such linear
relationships were observed between retention time and other
factors such as buffer pH (B), injection volume (D), and col-
umn oven temperature (E). Abrupt bending in the main effect
lines was observed for all the factors (except percentage (v/v)
of acetonitrile) signifying quadratic effect of a concerned fac-
tor. From the main effect plot (Fig. 1b), it was found that,
tailing factor was increased due to an increase in percentage
(v/v) of acetonitrile (A), buffer pH (B), injection volume (lL)
(D), and buffer molarity (F). However, no such direct inﬂuence
Figure 1 Main effect plots of means for showing the effect of factors (A, B, C, D, E, and F) upon retention time (a), tailing factor (b),
and theoretical plate (c). Where A, percentage (v/v) of acetonitrile; B, buffer pH; C, ﬂow rate (mL min1); D, injection volume (lL); E,
column oven temperature (C) and F, buffer molarity (mM).
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The sudden bending of the main effect lines in case of factors
such as buffer pH (B), ﬂow rate (mL min1) (C), injection vol-
ume (lL) (D) and column oven temperature (C) (E) justiﬁes
their quadratic effect. Similarly, as mentioned in Fig. 1c, theo-
retical plates were increased by increasing buffer pH (B) as well
as the column oven temperature (C) (E), while rest factors did
not a show a linear relationship with theoretical plates.3.3. Analysis of the S/N ratio and main effect ANOVA
TOA design uses the S/N ratio as quality characteristics of
three types of S/N ratios; the larger is better; the nominal is
best; the smaller is better (Sarıkaya and Gu¨llu¨, 2014). In this
study to achieve a better system suitability parameter, ‘‘the
smaller is a better’’ S/N ratio was selected. Table 2 represents
the S/N ratio, means, delta values, and ranks of each factor
presented at three levels. The F ratio obtained from the main
effect ANOVA (Table 3) was taken into consideration for
calculating the percentage contribution of each factor.
The rankings of factors (based on S/N ratio) upon retention
time were found to be as percentage (v/v) of acetonitrile
(A) > buffer molarity (mM) (F) > buffer pH (B) > ﬂow rate
(mL min1) (C) > column oven temperature (C)
(E) > injection volume (lL) (D). The F values and percentage
contribution of the individual factors obtained from the main
effect ANOVA (Table 3) equally supported the ranking of fac-
tors as suggested by S/N ratio. However, a slight change in the
ranking pattern was observed, as the contribution buffer
molarity (mM) (F) was higher than the percentage (v/v) of ace-
tonitrile (A). This might be associated with the errors while
calculating the S/N ratio in Taguchi design, where interaction
between factors is not considered (Montgomery, 2013).
Among all the factors, percentage (v/v) of acetonitrile (A), buf-
fer pH (B), ﬂow rate (mL min1) (C), and buffer molarity (mM)
(D) were signiﬁcantly (p< 0.05) affected retention time.
The ranking of factors affecting tailing factor is presented
in Table 2, and was found to be in the following order: buffer
pH (B) > buffer molarity (mM) (F) > percentage (v/v) of ace-
tonitrile (A) > injection volume (lL) (D) > ﬂow rate (mL
min1) (C) > column oven temperature (C) (E). This ranking
was equally supported from the ‘‘F value’’ as obtained in main
effect ANOVA (Table 3). All factors (except column oventemperature (C) (E)) were found to be signiﬁcantly
(p< 0.05) affecting tailing factor.
Buffer pH (B) was the alone factor, that had a signiﬁcant
(p< 0.05) effect upon theoretical plates, while the rest factors
remained non-signiﬁcant. As per the S/N ratio (Table 2) and F
values (Table 3), the rankings of factors affecting theoretical
plates are as buffer pH (B) > column oven temperature (C)
(E) > injection volume (lL) (D) > percentage (v/v) of ace-
tonitrile (A) > buffer molarity (mM) (F) > ﬂow rate
(mL min1) (C).
3.4. Visual interpretation from the contour plots as developed by
RSM
Contour plots were analyzed to visualize the effect of the fac-
tors on responses. Overlay contour plots describing the effect
of signiﬁcantly contributing factors upon retention time, tailing
factor and theoretical plates are shown in Fig. 2a–f. Small blue
circles inside contour plots represent actual data points. From
contour plots, a region of warm red color presents the highest
response; in contrast, a region of deep green color presents
the lowest one. It can be observed that a decrease in retention
time was associated with an increase in percentage (v/v) ace-
tonitrile (A), Flow rate (mL min1) (C) and buffer molarity
(mM) (F), which is equally supported for the main effect plot
(Fig. 1a) as discussed above. Similarly, for tailing factor and
theoretical plates, the factors behaved as the same way as men-
tioned in the main effect plot (Fig. 1b and c). Additionally,
Contour plots displayed curvature due to quadratic and/or
interaction effect in addition to the linear effects of a factor.
This justiﬁes the abrupt bending of response lines in the main
effect plot (Fig. 1) as discussed above.3.5. Analysis of the RSM based models
The observed and predicted values for each response are pre-
sented in Table 1. In order to identify the effect (linear,
square and interaction) of a factor upon the retention time;
the coefﬁcients obtained from regression analysis, were sub-
stituted in Eq. (2) to build the model equation for retention
time. The model terms having zero coefﬁcients were ignored
and the modiﬁed equation for retention time is presented in
Eq. (3).
Table 2 Response table showing means, signal to noise ratio (S/N), delta value and percentage contribution of each factor.
A B C D E F
S/Na ratio Mean S/Na ratio Mean S/Na ratio Mean S/Na ratio Mean S/Na ratio Mean S/Na ratio Mean
Retention time
Level 1 23.13 15.353 16.84 8.871 22.00 14.142 19.50 10.783 19.70 12.519 22.67 15.833
Level 2 18.74 10.303 18.25 8.930 19.18 9.911 19.15 11.679 19.13 9.989 18.38 9.300
Level 3 15.86 7.020 22.63 14.876 16.54 8.623 19.07 10.214 18.89 10.169 16.68 7.543
Delta 7.27 8.333 5.79 6.004 5.47 5.519 0.43 1.464 0.81 2.530 5.98 8.290
Rank 1 3 4 6 5 2
Tailing factor
Level 1 1.568 1.208 1.507 1.199 2.155 1.296 1.634 1.216 2.337 1.321 1.546 1.203
Level 2 2.158 1.289 1.900 1.251 1.850 1.243 2.260 1.306 2.007 1.267 2.130 1.284
Level 3 2.645 1.361 2.964 1.408 2.367 1.319 2.477 1.337 2.027 1.270 2.695 1.370
Delta 1.077 0.153 1.457 0.209 0.517 0.076 0.842 0.121 0.330 0.054 1.149 0.167
Rank 3 1 5 4 6 2
Theoretical plates
Level 1 77.58 7770 75.73 6223 77.68 7987 77.01 7264 76.47 6848 77.41 7827
Level 2 77.66 7882 77.55 7585 77.19 7374 77.97 8142 77.72 7767 77.71 7739
Level 3 77.08 7252 79.03 9097 77.44 7544 77.34 7499 78.13 8290 77.19 7338
Delta 0.58 630 3.30 2874 0.49 613 0.95 878 1.66 1441 0.52 489
Rank 4 1 6 3 2 5
A, percentage (v/v) of acetonitrile; B, buffer pH; C, ﬂow rate (mL min1); D, injection volume (lL); E, temperature of the column oven (C) and
F, buffer molarity (mM).
a S/N, signal-to-noise.
Table 3 Result obtained from main effect ANOVA analysis
of Taguchi design for responses.
Responses Eﬀect DFa Fb pc Percentage
contribution
Retention time (min)
A 2 24.5372 <0.001* 29.63
B 2 16.5720 <0.001* 20.01
C 2 11.6084 0.001* 14.02
D 2 0.7590 0.486 0.92
E 2 2.7747 0.096 3.35
F 2 26.5719 <0.001* 32.08
Tailing factor
A 2 16.23 <0.001* 18.96
B 2 32.60 <0.001* 38.08
C 2 4.13 0.039* 4.82
D 2 10.91 0.001* 12.75
E 2 2.57 0.112 3.00
F 2 19.16 <0.001* 22.38
Theoretical plates
A 2 0.5989 0.563 3.66
B 2 10.9411 0.001* 66.95
C 2 0.5309 0.599 3.25
D 2 1.0931 0.362 6.69
E 2 2.8181 0.094 17.24
F 2 0.3597 0.704 2.20
a DF, degree of freedom.
b F, test for comparing model variance with residual variance.
c p, probability of seeing the observed F-value if the null
hypothesis is true.
* Signiﬁcant at p< 0.05.
98 R.N. Dash et al.RT ¼ 107:0878 1:1365Aþ 0:0039A2  6:7999B
þ 0:9611B2  31:185Cþ 12:0136C2 þ 0:2644D
 0:0118D2  1:6624Eþ 0:0130E2  0:9736F
þ 0:0134F2 þ 0:0113AEþ 0:0268BE 0:0025CE
þ 0:0055DEþ 0:0055AF 0:0594BFþ 0:1184CF ð3Þ
where RT, retention time (min); A, percentage (v/v) of acetoni-
trile; B, buffer pH; C, ﬂow rate (mL min1); D, injection vol-
ume (lL); E, column oven temperature (C) and F, buffer
molarity (mM). The relationship between observed and pre-
dicted retention time was found to be linear with a good
correlation coefﬁcient (adjusted R2 = 0.9152), where a value
of the adjusted R2 greater than equal to 0.8 (adjusted
R2P 0.8) can be considered as acceptable for chemical sam-
ples (Lundstedt et al., 1998). The average difference between
the predicted and experimental retention time was approxi-
mately 0.87 min and the largest difference was 1.66 min. The
model F-value (15.76) along with p< 0.001 for the whole
model implied that the model is signiﬁcant.
A mathematical model was derived for the tailing factor as
below in Eq. (4) after ignoring the model terms having a zero
coefﬁcient.
TF ¼ 1:533061þ 0:003679A 0:00002A2  0:082472B
þ 0:017052B2  0:800113Cþ 0:521542C2
þ 0:008806D 0:000294D2  0:028522E
þ 0:000257E2 þ 0:011093Fþ 0:00001F2
þ 0:000952BEþ 0:000317CEþ 0:000278DE
þ 0:000128AF 0:002032BF 0:00254CF ð4Þ
where TF, tailing factor; A, percentage (v/v) of acetonitrile; B,
buffer pH; C, ﬂow rate (mL min1); D, injection volume (lL);
Figure 2 Contour plots for retention time (a, b), for tailing factor (c, d) and for theoretical plates (e, f). Where; A, percentage (v/v) of
acetonitrile; B, buffer pH and C, ﬂow rate (mL min1). Small blue circles represent actual data points. White arrow marks represent
optimized region.
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(mM). The model F-value of 13.12 with p< 0.001 implied that
the model was signiﬁcant. The relationship between observed
and predicted tailing factor was found to be linear, having a
good correlation coefﬁcient (adjusted R2 = 0.8985). The aver-
age and largest differences between predicted and experimental
tailing factor were found to be 0.019 and 0.06 respectively.
Similarly, the relation between theoretical plates and
different factors was presented as the model equation below
(Eq. (5)).
TP ¼ 12430:3þ 220:2A 1:6A2 þ 1260:1Bþ 24:5B2
 1833:6Cþ 3195:9C2 þ 517:1D 7:6D2 þ 197:2E
þ 2:3E2 þ 237:2F 0:8F2  0:5AEþ 0:2BE
 170:3CE 6:2DE 2:9AF 27:1BFþ 52:1CF ð5Þ
where TP, theoretical plates; A, percentage (v/v) of acetoni-
trile; B, buffer pH; C, ﬂow rate (mL min1); D, injection
volume (lL); E, column oven temperature (C) and F, buffer
molarity (mM). The Model ‘‘F-value’’ of 9.99 along with
p< 0.001 implied the model is signiﬁcant. The relationship
between observed and predicted theoretical plates was found
to be linear with an acceptable correlation coefﬁcient (adjusted
R2 = 0.8679). The average difference between predicted and
observed theoretical plates was approximately 264, with the
largest difference of 735.
3.6. Adequacies of the RSM based models
From the residual versus predicted plot (Fig. 3a–c), it can be
observed that the residuals for each response exhibited ahomogeneous pattern. Moreover, residuals were found to be
structure-less and independent with an almost equal scatter
above and below the zero-line of the residual plot. This implies
that the proposed models are adequate and the variance of the
experimental measurements is constant at all values of
responses. Hence, there is no reason to suspect any violation
of the independence or constant variance assumption
(Montgomery, 2013). Therefore, these models can be success-
fully used for the prediction of responses.
3.7. Derringer’s desirability for responses
Derringer’s desirability function uses a dimensionless desirabil-
ity value (d). The scale of d varies between 0 and 1. If d= 0,
then the response is undesirable to d= 1, where the response
is fully desirable. Hence, a value of 1 or closer to 1 is required
for getting a response of perfect target value (Derringer and
Suich, 1980). The individual desirability values can be summed
up to get a single value called global desirability (dG) and can
be represented as Eq. (6).
dG ¼ ½d p11 xd p22 x . . . x:d pnn 
1=n ð6Þ
where d1. . .dn is the individual desirability for 1. . .n number of
responses; p is the weight of the responses and was set equal to
1. The goal used for retention time and tailing factor was mini-
mized, whereas the goal was maximized for theoretical plates.
3.8. Optimization of the chromatographic method
Analyzing the obtained three-dimensional graphs, S/N ratio,
percentage contribution of each factor and desirability,
Figure 3 Predicted versus residual plot for retention time (a), tailing factor (b), and theoretical plates (c).
100 R.N. Dash et al.optimal chromatographic conditions were deﬁned to get a
chromatogram with lower tailing factor, higher theoretical
plates and a suitable capacity factor along with a reasonable
resolution to separate GLP from its major degradation prod-
ucts formed under various stress conditions. White color arrow
mark inside the contour plots (Fig. 2a–f) represents the
optimized region.
The global desirability was found to be close to 1 for each
response (RT= 0.982; TF= 0.982; TP= 0.951) at the fol-
lowing optimum conditions. Optimal conditions for the sep-
aration of GLP were achieved at a temperature of 35 ± 2 C
using acetonitrile – potassium dihydrogen phosphate (pH 4.0;
30 mM) (50:50, v/v). The ﬂow rate was kept at 1.0 mL min1
while the injection volume selected as 20 lL. The detection
wavelength selected was 229 nm.
These chromatographic conditions delivered chro-
matogram having a reasonable capacity factor (4.37) with bet-
ter plate count (7020) and lower tailing factor (1.25). The
resolutions between GLP, and its nearest degradants peak
were found to be greater than equal to 5.66, which was higher
than the required level (RsP 1.80) (Fig. 4). This in turn satis-
ﬁed the predetermined optimization goal criteria. To conﬁrm
these obtained results, six replicates injections of GLP
(20 lg mL1) were analyzed as a conﬁrmatory experiment dur-
ing system suitability testing.3.9. Method validation
3.9.1. Linearity, precision, accuracy, LOD and LOQ
GLP was found to be linear over the range 0.05–100 lg mL1
with a high correlation coefﬁcient (0.999). The regression equa-
tion for the calibration curve was found to be as below in Eq.
(7).
y ¼ 32308x 1227 ð7Þ
where y is the peak area (lV s) and x, the concentration of
GLP (lg mL1). The relative standard deviations for intra-
day and inter-day precisions were found to be less than 2%,indicating that the method was precise. In addition, accuracy
was found to be high, having a mean percentage recovery of
100.22. LOD and LOQ were found to be 0.02 and
0.05 lg mL1 respectively.
3.9.2. Speciﬁcity
The speciﬁcity of the HPLC method is illustrated in Figs. 4 and
5, where a complete separation of GLP in the presence of its
degradation products and excipients of S-SNEDDS (blank S-
SNEDDS) was noticed. The average retention time for GLP
was found to be 5.91 min. The peaks obtained were sharp hav-
ing clear baseline separation.
3.9.3. Robustness of the method
The results for robustness were remained unaffected by small
variations of the chromatographic parameters. The result from
the two columns indicated that there was no signiﬁcant differ-
ence between the results from the two columns. Nonsigniﬁcant
differences in retention time, tailing factor and theoretical
plates were observed.
3.9.4. System suitability
In the ﬁnal step, the optimization was veriﬁed by six
conﬁrmatory experiments and can be regarded as the system
suitability testing. The results for system suitability were found
to be within the acceptable limits.
3.10. Stability-indicating property
An analytical method is stability indicating if it can separate
all the process-related impurities and degradation products
from the parent peak. No degradation peaks were eluted
from the degradation mixture after the parent peak at
5.91–15 min; hence, the run time was selected as 10 min for
individual degradation samples. The overlay chromatogram
obtained from all the degradation conditions is presented in
Fig. 4. GLP was found to be highly degraded in acidic media,
where 91% of GLP were degraded by 48 h. GLP also found
AC
I
G
lim
ep
iri
de
F
B
G
H
E
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5
D
Figure 4 Overlay chromatogram for A, blank; B, acid degradation; C, base degradation; D, oxidative degradation; E, hydrolytic
degradation; F, dry heat degradation; G, moist heat degradation; H, photolytic degradation and I, standard GLP (20 lg mL1).
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Figure 5 Overlay chromatogram of A, S-SNEDDS blank; B, standard GLP (30 lg mL1) and C, S-SNEDDS of GLP.
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in 48 h. Oxidized stressed condition showed a major degrada-
tion peak at 1.21 min, and around 78% of GLP was found to
be degraded by 6 h. Hydrolytic degradation formed two dis-
tinct degradation peaks (at 2.10 and 2.40 min), and 78% of
GLP was found to be degraded at the end of ﬁfth days.
Dry heat and moist heat induced degradation gave rise to a
common degradation peak at 2.40 min. GLP was degraded
by 90% and 75% during dry heat and moist heat stressed
conditions respectively. Photolytic degradation eluted one
degradation peak (at 2.40 min) and degraded GLP by 75%.A common degradation peak (at 2.40 min) was observed in
case of hydrolytic, dry heat, moist heat and photolytic condi-
tion, while a degradation peak (at 2.10 min) was found to be
common for both hydrolytic and moist heat stressed
conditions.
These results indicate that GLP is susceptible to acid-base
hydrolysis, oxidative, thermal and photo degradation.
Adequate resolutions (RsP 5.66) between GLP and its nearest
degradation peaks were obtained under the different stressed
conditions. In all cases above, no degradation peaks were
found to interfere or co-eluted with GLP suggesting the
102 R.N. Dash et al.method enabled speciﬁc analysis of GLP in the presence of its
degradation products.
3.11. Analysis of GLP S-SNEDDS
From Fig. 5, it was observed that, no peaks from the excipient
(S-SNEDDS blank) were co-eluted at the GLP retention time.
The mean recovery of GLP from S-SNEDDS was found to be
100.29% indicating the non-interference from excipients.
Hence, the method is suitable for the quantiﬁcation of GLP
in the S-SNEDDS formulation.
4. Conclusion
This study demonstrated the worth of Taguchi orthogonal
array design combined with a response surface methodological
approach for the development of a robust stability indicating
HPLC method for the GLP. This approach exposed the two-
way interactions between factors, which were impossible to
detect with the Taguchi design alone. The critical factors that
are signiﬁcantly (p< 0.05) affecting the studied responses
were identiﬁed and controlled to achieve the predetermined
method goal. The best method having improved system suit-
ability parameters was employed in the routine assay of GLP
from an S-SNEDDS formulation. Lastly, the presented data
in the future will help analysts to diagnose any problems along
with corrective action, which may come across during the life
cycle of the stated stability indicating method, if applied for
other purposes involving quantitative estimation of glimepir-
ide provided speciﬁcity is justiﬁed for the intended purpose.
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